How to tell the difference between baby blues and postpartum depression
Moments after Jenna Carberg gave birth to her daughter, doctors put the baby on her chest. “I felt…
‘I quit Mounjaro after eggy burps then lost over 3st with 30p-a-day supplement’
Vicki McFarlane, 53, swapped expensive £180-a-month Mounjaro jabs for a cheap alternative found on Amazon and says the…
NHS 111 told her to take paracetamol; hours later she was in a coma |
She dialled 111 as her symptoms worsened. But the NHS 111 operator allegedly told her to take paracetamol.…
HIO tells doctors to switch diabetes patients to Ozempic as stocks run out
The Health Insurance Organisation (HIO) has announced that stocks of Victoza, a widely prescribed injectable diabetes medication, have…
Japan passes bill to raise co-payments for prescription drugs similar to OTC counterparts
Japan on Friday passed legislation to raise co-payments for prescription medicines with ingredients and effects similar to over-the-counter…
FDA seizes Rs 73 lakh meds for misleading claims in Maharashtra | Mumbai News
Mumbai: In a statewide crackdown on misleading drug advertisements and sale of misbranded medicines, the state Food and…
Taking Ozempic? Here’s What Experts Say You Should Be Eating
Brandon Bell Getty Images Millions of Americans are now taking Ozempic and other GLP-1 medications, and what ends…
Should you take the Ozempic pill or the shot? A doctor gives an honest answer
When the FDA approved an oral version of semaglutide in late 2025, the response was immediate. Patients who…
Batch of widely prescribed blood pressure drug recalled after packaging error
It follows a complaint from a health professional who found two blister strips of 10mg tablets inside a…
Kambo: What is the frog poison ‘spiritual ritual’ killing detoxers? | Government News
A number of people around the world have died after taking part in an ancient healing practice known…
Lilly’s Mounjaro tops other GLP-1s for some type 2 diabetes patients
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and…
Rilzabrutinib authorised to treat adults with immune thrombocytopenia when prior treatments have been insufficient
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (29 May 2026) granted a marketing authorisation for the medicines rilzabrutinib…